Platform LOL....Misleading has not proved it is working in any trial, all trials has failed. Guy is over his head with super responder buzzword he coined after tiny phase2a trial with loud mouth Macfarlane.
“ Or more likely Missling understands what the 2-73 platform is worth and is not willing to take an offer that does not represent that value.”
Or, this is how BP’s are born. The vision and ability of a one in a 100 CEO’s that have the ability to fund and lead a drug to market with the promise equal to or greater than blarcasamine.